Yüklüyor......
Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults
OBJECTIVE: Both sodium–glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) demonstrated cardiovascular benefits in randomized controlled trials of patients with type 2 diabetes (T2D) generally <65 years old and mostly with cardiovascular disease. We...
Kaydedildi:
| Yayımlandı: | Diabetes Care |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Diabetes Association
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7896266/ https://ncbi.nlm.nih.gov/pubmed/33495295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1464 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|